BioRestorative Therapies, Inc. — All Filings
725 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001493152-26-012925 | Mar 26, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | — | 0002027680-26-000001 | Feb 23, 2026 | — |
| SCHEDULE 13G | — | 0001213900-26-017939 | Feb 18, 2026 | — |
| SCHEDULE 13G/A | — | 0001700205-26-000003 | Feb 17, 2026 | — |
| 8-K | 8-K | 0001493152-26-006837 | Feb 17, 2026 | Feb 11, 2026 |
| 424B4 | 424B4 | 0001493152-26-006580 | Feb 13, 2026 | — |
| SCHEDULE 13G | — | 0001896206-26-000003 | Feb 13, 2026 | — |
| EFFECT | — | 9999999995-26-000543 | Feb 11, 2026 | — |
| S-1/A | S-1/A | 0001493152-26-006012 | Feb 10, 2026 | — |
| S-1 | S-1 | 0001493152-26-005827 | Feb 9, 2026 | — |
| DRS | — | 0001493152-25-028561 | Dec 19, 2025 | — |
| SCHEDULE 13G/A | — | 0002027680-25-000006 | Dec 19, 2025 | — |
| 424B3 | PROSPECTUS RE 508,592 SHARES OF COMMON STOCK | 0001021771-25-000152 | Dec 12, 2025 | — |
| EFFECT | — | 9999999995-25-003635 | Dec 10, 2025 | — |
| CORRESP | — | 0001021771-25-000150 | Dec 8, 2025 | — |
| S-1 | S-1 | 0001493152-25-024081 | Nov 18, 2025 | — |
| S-8 | S-8 | 0001493152-25-024082 | Nov 18, 2025 | — |
| 10-Q | 10-Q | 0001493152-25-021993 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | THIRD QUARTER 2025 FINANCIAL RESULTS | 0001021771-25-000148 | Nov 12, 2025 | — |
| 4 | — | 0001021771-25-000140 | Oct 20, 2025 | Oct 6, 2025 |
| 4 | — | 0001021771-25-000141 | Oct 20, 2025 | Oct 6, 2025 |
| D | — | 0001021771-25-000134 | Oct 9, 2025 | — |
| 8-K | 8-K | 0001493152-25-017446 | Oct 8, 2025 | Oct 6, 2025 |
| 424B5 | 424B5 | 0001493152-25-017433 | Oct 8, 2025 | — |
| 424B5 | 424B5 | 0001493152-25-017037 | Oct 6, 2025 | — |
| 8-K | ANNUAL MEETING VOTE | 0001021771-25-000131 | Sep 25, 2025 | Sep 18, 2025 |
| 8-K | PRESENTATION MATERIALS | 0001021771-25-000116 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001604867-25-000015 | Aug 14, 2025 | — |
| 8-K | Q2 2025 EARNINGS, BUSINESS UPDATE AND CONFERENCE CALL | 0001021771-25-000113 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-023211 | Aug 12, 2025 | Jun 30, 2025 |
| DEF 14A | DEF 14A | 0001641172-25-022812 | Aug 8, 2025 | — |
| 8-K | PRESENTATION - INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH | 0001021771-25-000092 | Jun 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001700205-25-000001 | May 15, 2025 | — |
| 10-Q | 10-Q | 0001641172-25-010299 | May 14, 2025 | Mar 31, 2025 |
| 8-K | FIRST QUARTER 2025 AND BUSINESS UPDATE CONFERENCE CALL | 0001021771-25-000079 | May 14, 2025 | — |
| 8-K | CHANGE IN ACCOUNTANTS | 0001021771-25-000074 | Apr 21, 2025 | Apr 16, 2025 |
| 10-K | — | 0001641172-25-001011 | Mar 28, 2025 | Dec 31, 2024 |
| 8-K | FINANCIAL RESULTS YEAR ENDED DECEMBER 31, 2024 AND CONFERENCE CALL | 0001021771-25-000066 | Mar 27, 2025 | — |
| SCHEDULE 13G/A | — | 0002027680-25-000003 | Feb 28, 2025 | — |
| SCHEDULE 13G/A | — | 0002027680-25-000002 | Feb 19, 2025 | — |
| SCHEDULE 13D/A | — | 0001021771-25-000050 | Feb 19, 2025 | — |
| 4 | — | 0001021771-25-000038 | Feb 19, 2025 | Feb 14, 2025 |
| 4 | — | 0001021771-25-000040 | Feb 19, 2025 | Feb 14, 2025 |
| 4 | — | 0001021771-25-000042 | Feb 19, 2025 | Feb 14, 2025 |
| 4 | — | 0001021771-25-000044 | Feb 19, 2025 | Feb 14, 2025 |
| 4 | — | 0001021771-25-000036 | Feb 19, 2025 | Feb 14, 2025 |
| 4 | — | 0001021771-25-000046 | Feb 19, 2025 | Feb 14, 2025 |
| SCHEDULE 13D/A | — | 0001021771-25-000048 | Feb 19, 2025 | — |
| 8-K | ORS PRESENTATION | 0001021771-25-000031 | Feb 10, 2025 | — |
| SCHEDULE 13G/A | — | 0002027680-25-000001 | Feb 10, 2025 | — |